Voyager Therapeutics(VYGR)
Focus: Voyager Therapeutics is a public biotechnology company specializing in AAV capsid gene therapy, headquartered in Lexington, MA. The company is focused on developing novel gene therapies for neurodegenerative diseases including Parkinson's, Huntington's, and Alzheimer's disease.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Voyager Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Voyager Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$250M
Key Products
VP4896
Stable
Growth
Only Phase 3 program in pipeline; represents primary near-term regulatory catalyst for company.
Pipeline & Clinical Trials
Help build intelligence for Voyager Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.